Upcoming Medical Conferences in BostonSearch Criteria : United States of America Boston
May 20 - 22, 2019 | CME 20.50 | USD $945 | Boston, Massachusetts
Diabetes Update 2019 is organized by Harvard Medical School (HMS), The Penzias Group and will be held from May 20 - 22, 2019 at Fairmont Copley Plaza, Boston, Boston, Massachusetts, United States of America. Who Should Attend: • Physicians • Nurse Practitioners • Physician Assistants • Nurses • Diabetes Educators • Psychologists • Pharmacists • Dietitians • Social Workers Earn up to: • 20.50 AMA PRA Category 1 Credits™ • 20.50 ABIM MOC points • 20.50 AAFP Prescribed credits • 20.50 CPEUs from the Commission on Dietetic Registration of the Academy of Nutrition and Dietetics The Comprehensive Harvard Medical School Diabetes Update: This Harvard Medical School CME program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care. • Expert guidance to design comprehensive treatment programs (non-pharmacological and pharmacological) for patients with diabetes • Guidance to account for biological, psychological, emotional, social, financial and cultural factors that impact the development and progression of diabetes • The newest data on the identification of patients at risk for type 2 diabetes and strategies to prevent or delay the disease process • The latest scientific information on the pathophysiology of type 2 diabetes and its implications in clinical practice • New guidelines and practice recommendations for nutrition and physical activity • How to navigate the recent and controversial data related to some antidiabetes medications • New technologies in diabetes care: updates and implications for day-to-day care • Research breakthroughs • Best practices that drive more effective treatment plans • Tips and tricks for navigating barriers within healthcare systems • Strategies to assess and improve low adherence to therapy Treating Special Populations: This program also provides comprehensive education to optimize the diabetes care you provide for special populations: • Racial and ethnic minorities • The elderly • Children and adolescents • Patients at low socio-economic levels • Patients with low health literacy/education • Patients with depression/emotional distress • The hospitalized patient with uncontrolled diabetes Practice Impact: In the course of three days, you will gain new, encompassing, evidence-based approaches to address the challenges seen in most clinical practices. More importantly, you will leave with knowledge - part art, part science - to make a real difference in the lives of your patients.
May 21, 2019 | CME 7.00 | USD $499 | Boston, Massachusetts
Lean Six Sigma White Belt is organized by Boston Children's Hospital and will be held on May 21, 2019 at Boston Children's Hospital, Boston, Massachusetts, United States of America. Target Audience • Physicians • Physician Assistants • Nurses • Nurse Practitioners • Pharmacists • Health Care Administration Accreditation: Physicians: Boston Children’s Hospital designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity. Nurses: Boston Children’s Hospital designates this activity for 7.00 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity. Pharmacists: Boston Children’s Hospital designates this activity for 7.00 contact hours for pharmacists. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. Overview: Continuous Improvement Training – Lean Six Sigma White Belt: Process Improvement Tools Lean Six Sigma is a combination of two proven continuous improvement methods: Lean and Six Sigma. Lean Six Sigma is focused on creating value for customers by improving efficiency, safety, and quality while reducing waste and variation. Want to change the world but not sure how? Learn some important process improvement tools that can help drive change in your part of the world. This goal of this introductory course is to teach the mindset and tools that are fundamental to the success of Lean and Six Sigma in healthcare. • White Belt is led by real-world practitioners, giving participants insight on how to apply these tools in their own job. • The day is meant to be interactive throughout, with small group exercises, class discussion, video examples, and active learning opportunities • Through the use of a simulated Emergency Department, participants get to apply six specific tools to improve a process: Eight Wastes, Process Mapping, Fishbone, 5S, Mistake Proofing, and Standard Work. Class begins at 8:00 am and concludes by 5:00 pm. There will be an hour for lunch around 12:00 pm and several breaks throughout the day. Upon completion of this course, you are eligible to sign up for the Lean Six Sigma Yellow Belt course. Objectives: • Describe the concept of involving everyone in continuous improvement • Discuss improving processes • Discuss the reasons for the change • Explain methodologies for continuous improvement used at the hospital • Recognize the requirements for change • Discuss methodologies for embracing change • Explain the need to view things from the customer’s perspective and practice empathetic listening techniques • Practice in a simulated process • Discuss some process analysis tools and identify 9 wastes • Define flow and determine how to clarify the flow of a process • Explain a fishbone diagram • Describe how to report an adverse event • Describe some continuous improvement tools and explain the 6S tool • Explain the mistake-proofing concept • Explain the problem with variation in the process and how standard work helps • Apply analysis and improvement tools to a simulated process • Develop an action plan
May 21, 2019 | CME 1.00 | Boston, Massachusetts
Genitourinary (GU) Tumor Board Conference is organized by Boston University School of Medicine Continuing Medical Education (BUSM CME) and will be held on May 21, 2019 at Boston Medical Center, Boston, Massachusetts, United States of America. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits™. Target Audience: The primary target for GU Tumor Board is attending and resident physicians (Urology, Medical Oncology, Radiation Oncology, Pathology, Radiology, Geriatrics) and also nurses and medical students. Course Objectives are : • Describe the optimum diagnostic techniques and treatment options for patients with urologic malignancies. • Describe the role of surgery and radiation therapy in the management of urologic malignancies. • Describe the role of chemotherapy and hormonal therapy in the management of urology malignancies. Additional details will be posted as soon as they are available.
May 21 - 23, 2019 | Boston, Massachusetts
5th Precision CRISPR Genome Editing Congress is organized by Hanson Wade and will be held from May 21 - 23, 2019 at The Westin Boston Waterfront, Boston, Massachusetts, United States of America. Description: Designed with CRISPR experts from AstraZeneca, AbbVie, Broad Institute, Casebia, Merck, Amgen and academics worldwide, this years 5th Precision CRISPR Genome Editing Congress encapsulates the critical scientific challenges and opportunities of CRISPR applications with regards to delivery, safety, precision, and efficiency to further optimize the relevant areas of drug discovery, functional screening & CRISPR-based cell & gene therapy. • Learn about how CRISPR is working in a clinical setting and unique approaches to gene therapy • Discover advances in disease modeling and strategies improving validation of human biology • Understand how we are harnessing novel CRISPR systems and the resulting expansion of the molecular toolbox • Explore how base editing is set to be the best technique for precision genome editing and the consequent applications in both basic biology and genetic diseases • Discover the wealth of CRISPR screening techniques available and how to implement them into your own drug discovery pipeline • Participate in forward-thinking debates and discussions crucial to advancing the infinite possibilities of CRISPR Engineering the Next Generation of Drug Discovery, Cell & Gene Therapy Applications Designed with CRISPR experts from the likes of CRISPR Therapeutics, Astrazeneca, AbbVie, Broad Institute, Casebia, Merck, Amgen and academic key opinion leaders, this year’s meeting encapsulates the critical scientific challenges and opportunities of CRISPR applications. Tackling delivery, safety, precision and efficiency best practice, further optimize your drug discovery, functional screening and translation of CRISPR-based cell and gene therapy into the clinic. With the first wave of CRISPR based therapeutic clinical trials firmly underway, the 5th Precision CRISPR Genome Editing Congress is perfectly timed to demonstrate the growing applications of CRISPR and unique approaches to gene therapy. Speakers: TJ Cradick, CRISPR Therapeutics, Jesper Gromada, Exonics Therapeutics, Beeke Wienert, Gladstone Institutes, San Francisc, George M. Church, PhD., Harvard Medical School, Niren Murthy, UC Berkeley, PJ Brooks, NIH Common Fund Program on Somatic Cell Genome Editing, Neville Sanjana, New York Genome Center and Departments of Biology and Neuroscience, Namjin Chung, AbbVie, Leire Escudero-Ibarz, GSK, Ben Kleinstiver, Harvard Medical School, Jonathan Gootenberg, MIT, Omar Abudayyeh, MIT, David Alvarado, Merck, Guru Channabasavaiah, University of Nebraska Medical Center, Stuart Chambers, Amgen, Ultan McDermott, AstraZeneca, Honorary Faculty, Garrett Rettig, IDT, Eric Paul Bennett, University of Copenhagen, Abraham Scaria, Casebia Therapeutics, Megan van Overbeek, Caribou Biosciences, Inc., Dan Tierno, Bayer, Bio-Rad Representative, Horizon Representative, Cellecta Representative Time: 8:00 am - 5:00 pm
May 22 - 24, 2019 | Boston, Massachusetts
1st Microbiome Movement - Maternal & Infant Health Summit is organized by Hanson Wade and will be held from May 22 - 24, 2019 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America. Conference Description: Compared to the development of microbiome-based products for adult disease, microbial-derived solutions for the pediatric setting have long been ignored. More recently, however, research investigating how the early life microbiome predisposes various health outcomes in infants is seeing an injection of scientific interest and investment. The inaugural Microbiome Movement - Maternal and Infant Health Summit has been established to improve your understanding of the fundamental maternal-infant microbiome mechanisms of action and advance translation of this causality into evidence-based and clinically validated therapeutic, nutritional and preventative solutions that will configure healthy foundations of the microbiome within the first 1000 days of life. This first-of-its-kind event is your opportunity to learn from the expertise of key opinion leaders from large pharma, biotech and academic research institutes presenting the latest case studies and in-depth discussion on key topics including: • Discovering the causal relationships between the maternal-infant microbiome and disease onset • Exploring different therapeutic products that restore the infant microbiome, as well as treat and prevent disease • Discussing study design for investigation of the microbiome in maternal and pediatric settings • Understanding the role of the maternal microbiome in preterm birth and infant health outcomes • Optimizing –omics and realizing how to integrate these data with novel pre-clinical modelling to generate clinically meaningful results • Explaining regulatory processes for IND-approved products targeting maternal and infant populations • Addressing public health, economic and educational considerations for commercializing microbiome-based products for mothers and infants There is no question that the pre-, peri- and postnatal maternal and infant microbiomes are critical windows of opportunity, that need to be acted upon today. Join us to unlock the therapeutic potential of the maternal-infant microbiome and proactively contribute to healthier clinical outcomes in new-borns brought into the world tomorrow. Early booking and group discounts apply, start-up and academic rates are available - see the website for details. Pre-Conference Workshop on May 22, 2019 Main Conference From May 23 - 24, 2019 Speakers: Alessio Fasano, Professor and Director Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Aurélien Baudot, International Business Development, ProDigest, Ben Callahan, Assistant Professor, NC State University, Bethany Henrick, Director, Immunology and Diagnostic, Evolve Biosystems, Cathryn Nagler, Bunning Food Allergy Professor, University of Chicago, John Colson, Director of Operations, ClostraBio, David Kyle, Executive Chairman and CSO, Evolve BioSystems, Deshanie Rai, Associate Adjunct Professor, Friedman School of Nutrition Science and Policy - Tufts University, Jeff Roberts, Medical Officer, Division of Vaccines and Related Product Applications, OVRR/CBER/FDA, Joseph Petrosino, CEO, Diversigen, Keith Martinez, Postdoctoral Fellow, Dominguez-Bello Lab, Rutgers University, Mark Heiman, CSO, Scioto Biosciences, Meghan Azad, Assistant Professor, Pediatrics and Child Health, University of Manitoba, Nitya Jain, Principal Investigator, Harvard Medical School, Noah Voreades, Consultant, GenBiome Consulting, Ryan Pace, Post-Doctoral Associate, Aagaard Lab, Baylor College of Medicine, Staffan Stromberg, CEO, Infant Bacterial Therapeutics, Tuval Ben-Yehezkel, CEO, Loop Genomics Time: 7:30 am - 5:15 pm
May 22, 2019 | CME 7.00 | USD $499 | Boston, Massachusetts
Lean Six Sigma Yellow Belt is organized by Boston Children's Hospital and will be held on May 22, 2019 at Boston Children's Hospital, Boston, Massachusetts, United States of America. Target Audience: • Physicians • Physician Assistants • Nurses • Nurse Practitioners • Pharmacists • Health Care Administration Accreditation: Physicians: Boston Children’s Hospital designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in this activity. Nurses: Boston Children’s Hospital designates this activity for 7 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity. Pharmacists: Boston Children’s Hospital designates this activity for 7 contact hours for pharmacists. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. Overview: Continuous Improvement Training – Lean Six Sigma Yellow Belt: Leading Process Improvement Projects Lean Six Sigma is a combination of two proven continuous improvement methods: Lean and Six Sigma. Lean Six Sigma is focused on creating value for customers by improving efficiency, safety, and quality while reducing waste and variation. Build on the tools learned in the White Belt class to understand how to lead process improvement projects. Participants learn how to use a proven five-step methodology called, DMAIC, to drive change in their organization. Specific tools and topics are covered for each of the five steps and participants are given the opportunity to practice in small groups. • Yellow Belt is led by real-world practitioners, giving participants insight on how to apply these tools in their own job. • The day is meant to be interactive throughout, with small group exercises, class discussion, video examples, and active learning opportunities • Included in the course: Team Charter, Value Analysis, Flow, Operational Definitions, 5 Why’s, Understanding Variation, Pareto Chart, Creative Thinking, Kanban, Visual Management, and Run Charts. Class begins at 8:00 am and concludes by 5:00 pm. There will be an hour for lunch around 12:00 pm and several breaks throughout the day. Objectives: • Describe the concept of involving everyone in continuous improvement • Explain the concept of leadership as part of everyone’s life • Describe the background, principles and tenets of Lean and Six Sigma and how it relates to the hospital • Explain Shewhart’s (Deming’s) PDCA/PDSA cycle • Describe the current continuous improvement projects and effort at the hospital • Define the meaning of a “process” • Explain the five-step continuous improvement methodology, DMAIC • Recognize a well-written charter • Review the use of a process map for looking at flow • Identify customer, operational and non-value added activities on a process flow diagram • Discuss the importance of an operational definition • Be able to recognize a well-written operational definition • Describe the 5 Why’s tool. Introduce basic statistical concepts including mean and standard deviation • Explain the Pareto Chart • Discuss creative thinking techniques • Explain Kanban concepts and implementation • Explain the concept of visual management • Describe the use of a run chart • Design an action plan
May 26 - 30, 2019 | Boston, Massachusetts
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics is organized by American Association for Cancer Research (AACR) and will be held from Oct 26 - 30, 2019 at Hynes Convention Center, Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.
May 28, 2019 | Boston, Massachusetts
ACRM-2 is organized by Center for Medical Simulation (CMS) and will be held on May 28, 2019 at Center For Medical Simulation, Boston, Massachusetts, United States of America. The target audience for this medical event is Anesthesiologists. Additional details will be posted as soon as they are available.
May 28 - 29, 2019 | USD $1895 | Boston, Massachusetts
Inhalation Drug Delivery Systems 2019 is organized by PharmaEd Resources, Inc and will be held from May 28 - 29, 2019 at Metro Meeting Centers-Boston, Boston, Massachusetts, United States of America. Featuring In-Depth Coverage On: • Regulatory Compliance Issues for Inhalation Therapies • Combination Product Design • Achieving An Inhaled Insulin Product • Developing A Generic Inhaled Product • Sterilization Issues Surrounding Inhalation Therapies • Extractables and Leachables Testing • Nebulizers, E-Cigarettes and Vaporizers: Past, present and future • Alternative Therapeutic Fields: Inhaled Antibiotics • Future directions in inhalation and respiratory drug delivery research • Novel Technologies For Pulmonary And Nasal Delivery • The Challenge Of Developing Inhalation Devices • Applying QbD Principles to Inhalation Therapies • Improving Patient Adherence With Product Design Fee: Standard Rate: $1,995- $2,495 depending on event Additional details will be posted as soon as they are available.
May 29 - 30, 2019 | Boston, Massachusetts
Skin Microbiome Congress is organized by Kisaco Research and will be held from May 29 - 30, 2019 at Boston, Massachusetts, United States of America. The target audience for this medical event is Multinational Beauty & Personal Care Companies, Multinational Pharmaceutical Companies, Skincare Brands & Biotechnology Companies, Formulators, Ingredients Suppliers & Packaging, Manufacturers, Sequencing Companies & Solution Providers. Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: • Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler application • Cutting Edge Research - Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiome • Consumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome • Clinical Trials - Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics • Competitive Edge - Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed products • Regulation - Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product Additional details will be posted as soon as they are available.